Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy

Journal of Cardiovascular Pharmacology
O E BroddeH R Zerkowski

Abstract

In end-stage heart failure, cardiac beta-adrenoceptors are decreased and cardiac Gi protein is increased. We assessed beta-adrenoceptors, G proteins, and effects of several beta-adrenoceptor agonists, histamine, and 5-HT on adenylyl cyclase activity in right and left atria and left ventricles and on left ventricular contractility in six potential heart transplant donors (nonfailing hearts; NFHs) and in nine patients with end-stage dilated cardiomyopathy (DCM) and 11 patients with end-stage ischemic cardiomyopathy (ICM) to establish whether the functional responsiveness of all cardiac Gs-coupled receptors is reduced. Beta-adrenoceptors were reduced in all three tissues; in DCM, beta1-adrenoceptors were more markedly downregulated; in ICM, both beta1- and beta2-adrenoceptors were diminished. In all three tissues, isoprenaline-, terbutaline-, histamine- and 5-HT-induced adenylyl cyclase activation was reduced similarly in DCM and ICM. Moreover, in DCM and ICM, guanosine triphosphate (GTP)- (involving Gs and Gi) activated adenylyl cyclase was significantly diminished, whereas NaF-activated (involving only Gs) and Mn2+-activated (acting at the catalytic unit of the enzyme) adenylyl cyclase was unaltered. Left ventricular positive in...Continue Reading

References

Apr 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·L Sanders, A J Kaumann
Jan 1, 1992·European Journal of Clinical Pharmacology·M SteinfathP Kalmár
Feb 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·M SteinfathH B Lo
Aug 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·A J KaumannM J Brown
Aug 1, 1990·British Journal of Pharmacology·A J KaumannM J Brown
Jul 1, 1989·Journal of Molecular and Cellular Cardiology·A R DennissJ D Marsh
Jun 1, 1989·European Heart Journal·O E BroddeM C Michel
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
May 1, 1983·Journal of Cardiovascular Pharmacology·A J BilskiJ L Wale
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S Strittmatter, E J Neer
Jul 1, 1995·Journal of Cardiovascular Pharmacology·O E BroddeH Oelert
Nov 7, 1993·Biochimica Et Biophysica Acta·M J Lohse
Aug 1, 1993·Cell Biology International·T Eschenhagen
Dec 1, 1993·The Journal of Clinical Investigation·M R BristowA M Feldman
Apr 6, 1993·Biochemical Pharmacology·M B Michel-ReherM C Michel
Jun 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·A J Kaumann, P Molenaar

❮ Previous
Next ❯

Citations

Mar 29, 2000·Cell Biochemistry and Biophysics·D J Choi, H A Rockman
Aug 12, 1999·European Journal of Pharmacology·C GiesslerO E Brodde
Aug 10, 2000·Journal of the American College of Cardiology·S DheinO E Brodde
Oct 24, 2002·Journal of the American College of Cardiology·Kirsten LeineweberOtto Erich Brodde
Oct 18, 2003·Journal of the American College of Cardiology·Kirsten LeineweberOtto Erich Brodde
Oct 13, 1998·Journal of the American College of Cardiology·H DrexlerG Hasenfuss
Feb 22, 2001·Annual Review of Physiology·J D Molkentin, G W Dorn
Dec 13, 2000·Journal of Molecular and Cellular Cardiology·T SeyfarthO E Brodde
Sep 1, 2000·Journal of Molecular and Cellular Cardiology·S Lu, A Hoey
Sep 15, 2012·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Astrid KassnerHendrik Milting
Dec 7, 2013·Molecular Nutrition & Food Research·Jan Kevin Schluesener, Hermann Schluesener
Oct 7, 2004·European Journal of Pharmacology·Otto-Erich Brodde, Kirsten Leineweber
Mar 17, 2018·The Journal of Clinical Endocrinology and Metabolism·Kasper Meidahl PetersenMikkel Bring Christensen
Dec 3, 2015·Circulation·Wenjun ZhangWeinian Shou
May 21, 2015·Circulation. Heart Failure·Martin M LeWinter, Bradley M Palmer
Mar 13, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas RauThomas Eschenhagen
Nov 1, 2003·The Journal of Pharmacology and Experimental Therapeutics·Armin KabatStefan Dhein
Apr 1, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Guoliang DingMary B Wagner
Aug 14, 1999·Progress in Biophysics and Molecular Biology·Y Shimoni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.